QIAGEN N.V. (QGEN) reported financial results for the second quarter of 2025 and also lifted its full-year net sales growth outlook. Net sales for the quarter rose 7 percent year-over-year to $534 million, or 6 percent at constant exchange rates. Net income reached $96 million, compared to a loss of $183 million in the same period last year. Earnings per share stood at $0.44, reversing a loss of $0.82 per share in the second quarter of 2024. On an adjusted basis, net income increased 8 percent to $132 million, while adjusted diluted EPS climbed 9 percent to $0.60. QIAGEN revised its full-year 2025 outlook, and now expects net sales to grow 4 to 5 percent at constant exchange rates, up from its prior forecast of around 4 percent. The company projects core business sales to grow 5 to 6 percent CER, excluding discontinued products.
QGEN closed Tuesday's trading at $49.95, down $0.30 or 0.60 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.